-

Salesforce’s Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement. This work will support AstraZeneca's commitment to push the boundaries of science to deliver life-changing medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology.

With Agentforce Life Sciences, Salesforce aims to help AstraZeneca unlock a new era of intelligent engagement — redefining customer relationships and accelerating business growth. The partnership will enable teams to focus on strategic customer outcomes and meaningful customer interactions.

Expanding its remit for AstraZeneca, Salesforce will support Agentforce 360 for Life Sciences as the global, end-to-end engagement solution for AstraZeneca, including:

  • Medical-Commercial Coordination: Consolidating healthcare professional (HCP) insights and surface context across teams.
  • Personalized Engagement: Scaling operations across key account, reimbursement, and field teams with next-best action recommendations. AstraZeneca will also orchestrate and automate digital campaigns across multiple channels based on customer preferences.
  • Model Context Protocol (MCP) Interoperability: Extending its composable architecture with Salesforce’s Agent Fabric, AstraZeneca will orchestrate internal and external agent actions across field engagement, commercial operations, and different brands and regions, allowing its care teams and AI agents to work seamlessly together.

“This partnership with AstraZeneca represents a clear step towards building intelligent, agentic customer engagement in the life sciences industry with their selection of Agentforce Life Sciences for Customer Engagement,” said Frank Defesche, SVP and GM of Life Sciences at Salesforce. “Together, we will empower AstraZeneca’s teams with the latest technology to deliver personalized engagement and accelerate the delivery of life-changing medicines to patients around the world.”

Learn more:

About Salesforce

Salesforce helps organizations of any size become Agentic Enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.com for more information.

Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

Contacts

Maha Neouchy
Salesforce
Public Relations
408-568-8442
pr@salesforce.com

Industry:

Salesforce

NYSE:CRM
Release Versions
English

Contacts

Maha Neouchy
Salesforce
Public Relations
408-568-8442
pr@salesforce.com

More News From Salesforce

Salesforce Commences Largest-Ever $25 Billion Accelerated Share Repurchase

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today commenced the prepayment and initial delivery of approximately 103 million shares under its previously announced $25 billion accelerated share repurchase (“ASR”) agreements that it entered into on March 11, 2026 with certain financial institutions. This transaction, the largest ASR in history, represents the immediate execution of half of the $50 billion aggregate Share Repurchase Program authorized by Salesfor...

Salesforce Prices Public Offering of Senior Notes

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that it has priced an underwritten offering (the “offering”) in aggregate principal amount of $25 billion in senior notes (the “notes”). The offering is expected to close on March 13, 2026, subject to the satisfaction of customary closing conditions. Salesforce intends to use all of the net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses payable by Sa...

Formula 1 and Salesforce Deepen Partnership, Expanding Agentforce to Grow Fan Connection Worldwide

SAN FRANCISCO & LONDON--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, and Formula 1 (NASDAQ: FWONA, FWONK, LLYVA, LLYVK), the world’s most popular annual sporting series, today announced the launch of a new fan companion agent to scale and personalize engagement for F1’s 827 million global fans. Developed as part of the multi-year partnership extension between Salesforce and Formula 1, the new agent will initially be available on F1.com and act as a vital tool to provide fans...
Back to Newsroom